The Technical Analyst
Select Language :
Ovid Therapeutics Inc [OVID]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Ovid Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Ovid Therapeutics Inc is listed at the  Exchange

0.00% $3.05

America/New_York / 28 mar 2024 @ 16:00


Ovid Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 215.67 mill
EPS: -0.740
P/E: -4.12
Earnings Date: May 03, 2024
SharesOutstanding: 70.71 mill
Avg Daily Volume: 0.211 mill
RATING 2024-03-28
B-
Sell
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Sell
Return On Asset: Sell
DE: Buy
P/E: Strong Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/a
Gr.Profitn/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -4.12 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.70x
Company: PE -4.12 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$-0.292
(-109.58%) $-3.34
Date: 2024-03-29
Expected Trading Range (DAY)

$ 2.87 - 3.25

( +/- 6.18%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-18 Levin Jeremy M Buy 18 248 Common Stock
2024-02-22 Tardio Jason Buy 168 750 Stock Option (Right to Buy)
2024-02-22 Tardio Jason Buy 28 125 Common Stock
2024-02-22 Rona Jeffrey A Buy 28 125 Common Stock
2024-02-22 Rona Jeffrey A Buy 168 750 Stock Option (Right to Buy)
INSIDER POWER
21.71
Last 96 transactions
Buy: 16 581 029 | Sell: 7 414 277

Forecast: 16:00 - $3.05

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $3.05
Forecast 2: 16:00 - $3.05
Forecast 3: 16:00 - $3.05
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $3.05 (0.00% )
Volume 0.138 mill
Avg. Vol. 0.211 mill
% of Avg. Vol 65.19 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Ovid Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Ovid Therapeutics Inc

RSI

Intraday RSI14 chart for Ovid Therapeutics Inc

Last 10 Buy & Sell Signals For OVID

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Ovid Therapeutics Inc

OVID

Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule for treating epilepsies. It also develops OV882, a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815 for the treatment of kinesin-family of proteins associated neurological disorder. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, and Northwestern University, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.

Last 10 Buy Signals

Date Signal @
AVTUSDMar 29 - 06:275.77
DIGGUSDMar 29 - 06:24899.52
HTUSDMar 29 - 06:23$0.867
CTXUSDMar 29 - 06:194.96
FUMOUSDMar 29 - 06:149 999
ORCAUSDMar 29 - 06:143.79
ORAIUSDMar 29 - 06:0714.49
FRAXUSDMar 29 - 06:08$0.996
CAHUSDMar 29 - 06:0737.41
BARUSDMar 29 - 06:083.56

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.